Explore evidence

32 %During the last 3 months of the trial, 32% of family planning clients were tested for HIV at control clinics in Mombasa, Kenya.

KenyaVIH/sidapublished 2022AIDS (London, England)europe_pmcdocument of 3 observations

0 seroconversionsNo HIV seroconversions were observed over the follow-up period.

KenyaVIH/sidapublished 2023JAMA network openPubMeddocument of 9 observations

19 %19% of women living with HIV agreed with at least three internalized stigma statements, indicating medium/high levels of internalized stigma.

KenyaVIH/sidaobserved 2015 to 2017published 2021BMC women's healthPubMeddocument of 7 observations

1.56 aHRDepot medroxyprogesterone acetate (DMPA) was significantly associated with elevated risk of HIV seroconversion in women with bacterial vaginosis (adjusted hazard ratio 1.56, 95% confidence interval 1.08–2.25).

Kenyavaginose bactérienne · VIH/sidaobserved 1993 to 2017published 2019AIDS (London, England)europe_pmcdocument of 4 observationsDOI 10.1097/qad.0000000000002167

2,257 individualsFrom October 2022 to December 2023, 2257 individuals were screened and 1915 were enrolled in the ePrEP Kenya pilot.

KenyaVIH/sidaobserved October 2022 to December 2023published 2025Journal of the International AIDS SocietyPubMeddocument of 19 observations

0 infectionsThere were no incident HIV infections in 400 person-years of follow-up in the intervention group.

KenyaVIH/sidapublished 2024The lancet. HIVPubMeddocument of 9 observations

96 %Of 25 participants with incident HIV infection, 24/25 (96%) started antiretroviral therapy (ART).

KenyaVIH/sidapublished 2021PLoS medicinePubMeddocument of 12 observations

15 %Adolescents comprise approximately 15% of new HIV infections in Kenya.

KenyaVIH/sidapublished 2023AIDS education and prevention : official publication of the International Society for AIDSPubMeddocument of 2 observations

2.71 odds_ratioIn a cohort of 309 adolescent girls and young women aged 15–24 years living with HIV in Kisumu County, western Kenya, substance use was associated with significantly higher odds of poor antiretroviral therapy adherence (Odds Ratio = 2.71).

KenyaVIH/sidaobserved January to June 2022published 2023International journal of environmental research and public healthPubMeddocument of 4 observations

60 %Male circumcision provides men with approximately 60% protection from acquiring HIV infection via heterosexual sex.

KenyaVIH/sidapublished 2018BMC infectious diseaseseurope_pmcdocument of 2 observations

95 %Ninety-five percent of adolescents and young adults living with HIV were virally suppressed.

KenyaVIH/sidapublished 2026Journal of the International Association of Providers of AIDS CarePubMeddocument of 8 observations

0.9 %In a prospective study of HIV incidence in African women in Eswatini, Kenya, South Africa, and Zambia, true positive HIV results occurred at 412 visits (0.9%) out of 48,234 visits.

Afrique du Sud · Kenya · ZambieVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

3.97 RRRHIV status was associated with higher odds of dual method use, with a ratio of relative risk of 3.97.

KenyaVIH/sidaobserved 2015 to 2016published 2023ContraceptionPubMeddocument of 6 observations

25 %Among adolescents living with HIV (ALH) in school, 25% in day schools self-reported missing antiretroviral therapy (ART) when school was in session.

KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 14 observations

26 %In Kenya, family testing contributed 26% of the total number of children identified with HIV.

KenyaVIH/sidaobserved 2015–2016published 2020International journal of STD & AIDSPubMeddocument of 7 observations

18 %A restrictive spirometry pattern (RSP) was observed in 18% of adolescents with HIV in Nairobi, Kenya.

KenyaVIH/sidapublished 2025ChestPubMeddocument of 9 observations

28 %Of those screened for PrEP eligibility, 28% of female sex workers (FSW) were ineligible.

KenyaVIH/sidaobserved February 2017 to December 2019published 2020Journal of the International AIDS SocietyPubMeddocument of 13 observations

33.5 %The cumulative risk of loss to follow-up for people living with HIV prior to antiretroviral therapy initiation 12 months after enrollment was 33.5% (95% CI 33.36–33.58).

KenyaVIH/sidapublished 2020PloS onePubMeddocument of 12 observations

240 casesThere were 240 (31%, 95%CI 27 to 34%) people living with HIV with poor outcomes after 24 months.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 15 observations

68.1 %Among women with HIV in serodifferent relationships in Nairobi, Kenya who reported intimate partner violence in the past year, 68.1% reported emotional violence.

KenyaVIH/sidapublished 2022PloS onePubMeddocument of 8 observations

2.11 incidence_rate_ratioChart audits were associated with an incidence rate ratio of 2.11 for increased HIV testing among adolescents.

KenyaVIH/sidaobserved October 2015 to September 2016published 2022AIDS carePubMeddocument of 16 observations

A randomized controlled trial is comparing home-based couples intervention and HIV self-testing for couples among pregnant women attending antenatal care clinics in two counties in southwestern Kenya.

KenyaVIH/sidapublished 2023Value in health regional issuesPubMeddocument of 10 observations

1.95 prevalence_ratioFemale sex workers originating from a high-prevalence county in Kenya had a prevalence ratio of 1.95 for living with HIV in adjusted analysis.

KenyaVIH/sidaobserved 2014 to 2017published 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

19 %Awareness of oral HIVST was low (19%).

KenyaVIH/sidapublished 2023AIDS carePubMeddocument of 5 observations

14.2 %Among patients with underlying conditions in Kenya's hospitalized COVID-19 cohort, HIV was present in 14.2%.

KenyaCOVID-19 · VIH/sidapublished 2025Global health actionPubMeddocument of 11 observations